NO955326D0 - Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse - Google Patents

Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO955326D0
NO955326D0 NO955326A NO955326A NO955326D0 NO 955326 D0 NO955326 D0 NO 955326D0 NO 955326 A NO955326 A NO 955326A NO 955326 A NO955326 A NO 955326A NO 955326 D0 NO955326 D0 NO 955326D0
Authority
NO
Norway
Prior art keywords
preparation
therapeutic use
isoquinoline derivatives
isoquinoline
derivatives
Prior art date
Application number
NO955326A
Other languages
English (en)
Other versions
NO955326L (no
Inventor
Mireille Sevrin
Benoit Marabout
Jacques Froissant
Catherine Guinot
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO955326D0 publication Critical patent/NO955326D0/no
Publication of NO955326L publication Critical patent/NO955326L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO955326A 1994-12-29 1995-12-28 Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse NO955326L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415837A FR2728900B1 (fr) 1994-12-29 1994-12-29 Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO955326D0 true NO955326D0 (no) 1995-12-28
NO955326L NO955326L (no) 1996-07-01

Family

ID=9470390

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955326A NO955326L (no) 1994-12-29 1995-12-28 Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse

Country Status (22)

Country Link
US (1) US5665733A (no)
EP (1) EP0719764B1 (no)
JP (1) JPH08239365A (no)
KR (1) KR960022472A (no)
CN (1) CN1131150A (no)
AR (1) AR002016A1 (no)
AT (1) ATE172966T1 (no)
AU (1) AU698595B2 (no)
BR (1) BR9506106A (no)
CA (1) CA2166234A1 (no)
CO (1) CO4700298A1 (no)
CZ (1) CZ348995A3 (no)
DE (1) DE69505780D1 (no)
FI (1) FI956298A (no)
FR (1) FR2728900B1 (no)
HU (1) HU215394B (no)
IL (1) IL116590A0 (no)
NO (1) NO955326L (no)
NZ (1) NZ280765A (no)
PL (1) PL312079A1 (no)
SK (1) SK165795A3 (no)
ZA (1) ZA9511046B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2750427B1 (fr) * 1996-06-28 1998-08-07 Synthelabo Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
FR2772758B1 (fr) * 1997-12-22 2000-02-04 Synthelabo Derives de 1-oxo-1,2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
EP1572660B1 (en) * 2002-12-20 2011-01-26 X-Ceptor Therapeutics, Inc. Isoquinolinone derivatives and their use as therapeutic agents
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AU2007283570A1 (en) * 2006-08-10 2008-02-14 Ferrer Internacional S.A. 1H-quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions
EP1886996A1 (en) * 2006-08-10 2008-02-13 Ferrer Internacional, S.A. 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions
US8741917B2 (en) 2009-01-15 2014-06-03 Rutgers, The State University Of New Jersey Benzo [C] phenanthridines as antimicrobial agents
US20120059026A1 (en) 2009-04-30 2012-03-08 University Of Medicine And Dentistry Of New Jersey Antimicrobial agents
FR2956816B1 (fr) * 2010-03-01 2012-05-18 Univ Joseph Fourier Utilisation de quinolones pour la preparation de medicaments, nouvelles quinolones et leur procede de synthese
WO2011156626A1 (en) 2010-06-09 2011-12-15 Rutgers, The State University Of New Jersey Antimicrobial agents
CA2803890A1 (en) 2010-06-25 2011-12-29 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013106756A2 (en) 2012-01-13 2013-07-18 Rutgers, The State University Of New Jersey Antimicrobial agents
AU2013235038A1 (en) 2012-03-21 2014-10-09 Malvika Kaul Antimicrobial agents
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
CN109195957A (zh) 2016-02-25 2019-01-11 塔克西斯医药股份有限公司 合成方法和中间体
WO2018183917A1 (en) 2017-03-30 2018-10-04 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates
EP4126858A1 (en) * 2020-03-26 2023-02-08 Richter Gedeon Nyrt. Dihydro-2-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators
TW202202495A (zh) * 2020-03-26 2022-01-16 匈牙利商羅特格登公司 作為ｇａｍｍａ－胺基丁酸Ａ受體次單元ａｌｐｈａ ５受體調節劑之㖠啶及吡啶并〔３，４－ｃ〕嗒𠯤衍生物

Also Published As

Publication number Publication date
FI956298A (fi) 1996-06-30
KR960022472A (ko) 1996-07-18
HU9503848D0 (en) 1996-02-28
AR002016A1 (es) 1998-01-07
EP0719764B1 (fr) 1998-11-04
FR2728900B1 (fr) 1997-01-31
JPH08239365A (ja) 1996-09-17
NZ280765A (en) 1996-08-27
HUT74187A (en) 1996-11-28
DE69505780D1 (de) 1998-12-10
SK165795A3 (en) 1996-07-03
FI956298A0 (fi) 1995-12-28
ATE172966T1 (de) 1998-11-15
EP0719764A1 (fr) 1996-07-03
BR9506106A (pt) 1997-12-23
CZ348995A3 (en) 1996-07-17
AU698595B2 (en) 1998-11-05
US5665733A (en) 1997-09-09
NO955326L (no) 1996-07-01
CN1131150A (zh) 1996-09-18
IL116590A0 (en) 1996-03-31
HU215394B (hu) 1998-12-28
ZA9511046B (en) 1996-07-11
AU4071295A (en) 1996-07-04
PL312079A1 (en) 1996-07-08
CA2166234A1 (en) 1996-06-30
FR2728900A1 (fr) 1996-07-05
CO4700298A1 (es) 1998-12-29

Similar Documents

Publication Publication Date Title
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO944187L (no) Isokinoliner, fremgangsmåte for deres fremstilling og anvendelse
NO924650D0 (no) Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
NO963499D0 (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO955326D0 (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO922275D0 (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
NO943794D0 (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
NO975020D0 (no) Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
NO985248D0 (no) Indolylpyrrolydenmetylpyrrolderivater og fremgangsmÕte for deres fremstilling
NO962477L (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
DK0701554T3 (da) Benzisoselen-azolinderivater og -azinderivater, fremgangsmåde til fremstilling heraf og deres terapeutiske anvendelse
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
NO934227D0 (no) Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse
NO951811D0 (no) Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO981002D0 (no) Karboksylsyrederivater, deres fremstilling og anvendelse
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
NO950560D0 (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse